Watch to meet lymphoma oncologist Christopher Flowers, M.D.
MD Anderson at ASH
MD Anderson’s patient-centric approach to research is advancing the understanding of malignant and non-malignant blood disorders and extending patients’ lives. At the ASH Annual Meeting and Exposition, our experts showcase their practice-changing work with colleagues from across the globe for large-scale discussion.
Keep up with presentation highlights from our experts as well as learn more about our pioneering research across the field of hematology below.
Featured Articles
New clinical studies from our Dr. Sattva Neelapu and Dr. Jason Westin demonstrate enhanced responses for patients with high-risk lymphoma treated with axicabtagene ciloleucel CAR T cell therapy.
MD Anderson Research Highlights: ASH 2021 Special Edition
This special edition features presentations at the 2021 ASH Annual Meeting on innovative targeted therapies, new combination approaches, and novel cellular therapies to improve treatments for patients with leukemia, lymphoma and other hematologic cancers.
Naval Daver, M.D., and Sangeetha Venugopal, M.D., present data on new combinations for particularly difficult to treat subtypes of acute myeloid leukemias.
Meet the Experts
Stop by booth 1212 to ask a question, learn about training and career opportunities and continue the conversation on key presentations with our experts.
Saturday, Dec. 11
Robert Orlowksi, M.D., Ph.D.
Myeloma
2-2:30 p.m. ET
Sunday, Dec. 13
Loretta Nastoupil, M.D.
Lymphoma
10-10:30 a.m. ET
Naval Daver,
M.D.
Leukemia
1-1:30 p.m. ET
William Wierda, M.D., Ph.D.
Leukemia
3-4 p.m. ET
MD Anderson News
Meet Our Experts
Moon Shots Program
MD Anderson’s Moon Shots Program® aims to rapidly and dramatically improve cancer survival rates and reduce suffering through early detection, research and new treatments.
Learn more